drugset

drugset / Trial / NCT00705861

Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus

NCT00705861 ↗

Phase 3 Completed 112 enrolled SK Chemicals Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of SK3530 on erectile dysfunction in Patients with Diabetes Mellitus.

Timeline

Start: 2007-11
Primary completion: 2008-07
Completion: 2008-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mirodenafil	Small molecule	100 mg	—

Indications